Skip to main content
MarketStoryBook

Danaher Corporation in 1 story

The narratives DHR currently appears in, with its side and exposure in each.

Bull side

1 story
  • GLP-1 Eats Everything

    DHR in “GLP-1 Eats Everything”

    FadingExposure: not rated yet

    Appetite suppression as a macro variable.

    Danaher's life-science tools and bioprocessing businesses can benefit from drugmakers expanding development, analytical testing, and manufacturing capacity for metabolic medicines.

Bear side

0 stories

No bear-side stories for DHR yet.